Literature DB >> 31829411

An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics.

Aoife Harbison1, Elisa Fadda1.   

Abstract

The immunoglobulin type G (IgG) Fc N-glycans are known to modulate the interaction with membrane-bound Fc γ receptors (FcγRs), fine-tuning the antibody's effector function in a sequence-dependent manner. Particularly interesting in this respect are the roles of galactosylation, which levels are linked to autoimmune conditions and aging, of core fucosylation, which is known to reduce significantly the antibody-dependent cellular cytotoxicity (ADCC), and of sialylation, which also reduces antibody-dependent cellular cytotoxicity (ADCC) but only in the context of core-fucosylation. In this article, we provide an atomistic level perspective through enhanced sampling computer simulations, based on replica exchange molecular dynamics (REMD), to understand the molecular determinants linking the Fc N-glycans sequence to the observed IgG1 function. Our results indicate that the two symmetrically opposed N-glycans interact extensively through their core trimannose residues. At room temperature, the terminal galactose on the α (1-6) arm is restrained to the protein through a network of interactions that keep the arm outstretched; meanwhile, the α (1-3) arm extends toward the solvent where a terminal sialic acid remains fully accessible. We also find that the presence of core fucose interferes with the extended sialylated α (1-3) arm, altering its conformational propensity and as a consequence of steric hindrance, significantly enhancing the Fc dynamics. Furthermore, structural analysis shows that the core-fucose position within the Fc core obstructs the access of N162 glycosylated FcγRs very much like a "door-stop," potentially decreasing the IgG/FcγR binding free energy. These results provide an atomistic level-of-detail framework for the design of high potency IgG1 Fc N-glycoforms.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADCC; Fc-N-glycans; IgG1; REMD; molecular dynamics

Year:  2020        PMID: 31829411     DOI: 10.1093/glycob/cwz101

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  8 in total

1.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

2.  TETRALEC, Artificial Tetrameric Lectins: A Tool to Screen Ligand and Pathogen Interactions.

Authors:  Silvia Achilli; João T Monteiro; Sonia Serna; Sabine Mayer-Lambertz; Michel Thépaut; Aline Le Roy; Christine Ebel; Niels-Christian Reichardt; Bernd Lepenies; Franck Fieschi; Corinne Vivès
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

3.  Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.

Authors:  Oliver C Grant; David Montgomery; Keigo Ito; Robert J Woods
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

4.  Going Native: Synthesis of Glycoproteins and Glycopeptides via Native Linkages To Study Glycan-Specific Roles in the Immune System.

Authors:  Mikkel H S Marqvorsen; Can Araman; Sander I van Kasteren
Journal:  Bioconjug Chem       Date:  2019-10-18       Impact factor: 4.774

5.  Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition.

Authors:  Oliver C Grant; David Montgomery; Keigo Ito; Robert J Woods
Journal:  bioRxiv       Date:  2020-05-01

6.  Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.

Authors:  Gennady M Verkhivker
Journal:  J Proteome Res       Date:  2020-10-02       Impact factor: 4.466

7.  Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.

Authors:  Austen Bernardi; Yihan Huang; Bradley Harris; Yongao Xiong; Somen Nandi; Karen A McDonald; Roland Faller
Journal:  PLoS One       Date:  2020-08-05       Impact factor: 3.240

8.  Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis.

Authors:  David A Spencer; Benjamin S Goldberg; Shilpi Pandey; Tracy Ordonez; Jérémy Dufloo; Philip Barnette; William F Sutton; Heidi Henderson; Rebecca Agnor; Lina Gao; Timothée Bruel; Olivier Schwartz; Nancy L Haigwood; Margaret E Ackerman; Ann J Hessell
Journal:  Nat Commun       Date:  2022-02-03       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.